Edition:
United States

Search Results  for '600196.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Shanghai Fosun Pharmaceutical Group Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Shanghai Fosun Pharmaceutical Group Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Shanghai Fosun Pharmaceutical Group Co Ltd (600196-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

23 Aug 2016 Thomson Reuters Stock Report 11 $25.00

Thomson Reuters Stock Report - Shanghai Fosun Pharmaceutical Group Co Ltd (2196-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

23 Aug 2016 Thomson Reuters Stock Report 11 $25.00

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial Analysis Review

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial Analysis Review Summary Shanghai Fosun Pharmaceutical (G...

22 Aug 2016 GlobalData 105 $300.00

京 華 山 一 [復星醫藥(600196 CH):收購打開海外銷售市場](01/08/2016)

最新發展 復星醫藥業務主要分為三大板塊:藥品製造與研發、醫療服務及醫學診斷與醫療器械製造。 催化劑 新品重磅藥儲備豐富。公司16年上半年已有兩款重磅首仿藥獲批進入臨床試驗階段:卡格列淨片(Ⅱ型糖尿病)及枸櫞酸托法替布片(風濕性關節炎)。兩款...

04 Aug 2016 Core Pacific - Yamaichi International (H.K.) Limited 3 $12.00

Monthly Stock Picks - China - August 2016

02 Aug 2016 Sadif Analytics Prime 7 $25.00

公司新闻:复星医药(02196.HK)收购印度同行Gland Pharma86%股权

29 Jul 2016 Guotai JunAn (HK) Research 22 $207.00

Wright Investors Service Comprehensive Report for Shanghai Fosun Pharmaceutical (Group) Company Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

22 Jul 2016 Wright Reports 62 $75.00

Is There Long-Term Value in Shanghai Fosun Pharmaceutical (Group)?

28 Jun 2016 Sadif Analytics Prime 12 $25.00